Search Results for agency_names:"National Institutes of Health"

The National Cancer Institute, part of the National Institutes of Health, is considering granting an exclusive patent license to Kyverna Therapeutics. This license would allow Kyverna to use certain patented inventions to develop a therapy using chimeric antigen receptors (CAR) targeting CD19 for treating autoimmune diseases. The CAR technology uses CRISPR/Cas9-edited T cells to recognize and attack cells expressing the CD19 protein, potentially offering a new treatment option for diseases such as lupus nephritis. Comments or objections to this proposed license must be submitted by March 5, 2021.

The National Institute on Alcohol Abuse and Alcoholism has announced a closed meeting of the Special Emphasis Panel to review and evaluate contract proposals. This meeting will take place on February 4, 2025, from 1:00 p.m. to 4:00 p.m. and will be conducted virtually. The discussion will involve confidential material, including trade secrets and personal information, which is why the meeting will not be open to the public. Interested parties should contact Dr. Beata Buzas for more information.

The National Institute on Aging is holding a meeting focused on evaluating grant applications for a clinical trial involving older individuals. This meeting, scheduled for February 26, 2021, from 11:00 a.m. to 5:00 p.m., will be closed to the public due to the potential disclosure of confidential information such as trade secrets and personal data. The meeting will take place via video at the Gateway Building in Bethesda, Maryland, and will be led by Dr. Maurizio Grimaldi, a Scientific Review Officer.

In accordance with the Federal Advisory Committee Act, the National Institutes of Health (NIH) announced that several meetings of the Center for Scientific Review will be held virtually. These meetings, taking place between March 19 and March 24, 2021, are closed to the public due to the sensitive nature of the discussions, which include evaluating grant applications and potential disclosure of confidential materials. The subject matter of the meetings ranges from drug discovery and neurodegenerative disorders to HIV/AIDS prevention and treatment, with various scientific review officers assigned to manage the sessions. These sessions aim to review and evaluate various grant proposals, ensuring that personal privacy and proprietary information remain protected.

The National Institute on Aging, part of the National Institutes of Health, announced a meeting that will be closed to the public. This meeting, scheduled for February 18, 2021, is intended to review and evaluate grant applications related to aging therapeutics. The meeting is closed to protect confidential information and personal privacy as required by specific U.S. legal provisions. The meeting will take place via a video meeting at the National Institute on Aging in Bethesda, Maryland, and will be managed by Dr. Birgit Neuhuber.

The Center for Scientific Review is holding several closed meetings to review grant applications for various research projects. These meetings, held under the Federal Advisory Committee Act, are not open to the public because they may involve confidential information such as trade secrets or personal data. The meetings will assess projects related to open science and research software engineering and will take place virtually between March 28 and April 3, 2025. Contact persons for the meetings are provided, including Megan Lynne Goodall, John Harold Laity, and Joonil Seog, along with their contact details.

The National Heart, Lung, and Blood Advisory Council will hold a virtual meeting on February 4, 2025. The meeting is open to the public from 9:30 a.m. to 3:00 p.m., where program policies and issues will be discussed. It will start with a closed session from 9:00 a.m. to 9:30 a.m. dedicated to reviewing grant applications. The public can watch the meeting through the NIH Videocast website, and those interested in making oral comments to the committee should notify the contact person at least ten days before the meeting.

The National Institute of Allergy and Infectious Diseases is holding a closed meeting to review grant applications for the NIAID New Innovators Awards. The meeting will take place virtually on March 2-3, 2021, from 10:00 a.m. to 6:00 p.m. The discussions will include sensitive information, such as trade secrets and personal data, which is why the meeting is not open to the public. Jennifer H. Meyers, a Scientific Review Officer, can be contacted for more information.

The Center for Scientific Review within the National Institutes of Health announced a closed meeting scheduled for January 6, 2025. This meeting will focus on reviewing and evaluating grant applications related to health services and systems, and it will be held virtually. Due to confidential discussions involving trade secrets or personal information, the meeting will not be open to the public. For more details, Tara Roshell Earl, Ph.D., serves as the contact person for this event.

The National Deafness and Other Communication Disorders Advisory Council will hold a virtual meeting on May 9, 2025, from 9:00 a.m. to 12:00 p.m. This meeting is closed to the public to protect confidential information related to grant applications. The council will discuss and evaluate these applications, and any additional information will be shared on their website. For further details, contact Rebecca Wagenaar-Miller, Ph.D. at the National Institutes of Health.